Literature DB >> 8570646

Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

G Venkataraman1, V Sasisekharan, A B Herr, D M Ornitz, G Waksman, C L Cooney, R Langer, R Sasisekharan.   

Abstract

Central to signaling by fibroblast growth factors (FGFs) is the oligomeric interaction of the growth factor and its high-affinity cell surface receptor, which is mediated by heparin-like polysaccharides. It has been proposed that the binding of heparin-like polysaccharides to FGF induces a conformational change in FGF, resulting in the formation of FGF dimers or oligomers, and this biologically active form is 'presented' to the FGF receptor for signal transduction. In this study, we show that monomeric basic FGF (FGF-2) preferentially self-associates and forms FGF-2 dimers and higher-order oligomers. As a consequence, FGF-2 monomers are oriented for binding to heparin-like polysaccharides. We also show that heparin-like polysaccharides can readily bind to self-associated FGF-2 without causing a conformational change in FGF-2 or disrupting the FGF-2 self-association, but that the bound polysaccharides only additionally stabilize the FGF-2 self-association. The preferential self-association corresponds to FGF-2 translations along two of the unit cell axes of the FGF-2 crystal structures. These two axes represent the two possible heparin binding directions, whereas the receptor binding sites are oriented along the third axis. Thus, we propose that preferential FGF-2 self-association, further stabilized by heparin, like "beads on a string," mediates FGF-2-induced receptor dimerization and activation. The observed FGF-2 self-association, modulated by heparin, not only provides a mechanism of growth factor activation but also represents a regulatory mechanism governing FGF-2 biological activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8570646      PMCID: PMC40145          DOI: 10.1073/pnas.93.2.845

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.

Authors:  D Aviezer; D Hecht; M Safran; M Eisinger; G David; A Yayon
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

Review 2.  The coordinated regulation of heparan sulfate, syndecans and cell behavior.

Authors:  A C Rapraeger
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

Review 3.  The ins and outs of fibroblast growth factors.

Authors:  I J Mason
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

4.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.

Authors:  M Roghani; A Mansukhani; P Dell'Era; P Bellosta; C Basilico; D B Rifkin; D Moscatelli
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

5.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.

Authors:  S Guimond; M Maccarana; B B Olwin; U Lindahl; A C Rapraeger
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

6.  Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor.

Authors:  M Ishihara; D J Tyrrell; G B Stauber; S Brown; L S Cousens; R J Stack
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

7.  Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.

Authors:  M Maccarana; B Casu; U Lindahl
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

8.  N.m.r. and molecular-modelling studies of the solution conformation of heparin.

Authors:  B Mulloy; M J Forster; C Jones; D B Davies
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

9.  Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.

Authors:  B A Springer; M W Pantoliano; F A Barbera; P L Gunyuzlu; L D Thompson; W F Herblin; S A Rosenfeld; G W Book
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

10.  Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.

Authors:  T Spivak-Kroizman; M A Lemmon; I Dikic; J E Ladbury; D Pinchasi; J Huang; M Jaye; G Crumley; J Schlessinger; I Lax
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

View more
  15 in total

1.  Oligomeric self-association of basic fibroblast growth factor in the absence of heparin-like glycosaminoglycans.

Authors:  J C Davis; G Venkataraman; Z Shriver; P A Raj; R Sasisekharan
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

2.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

Authors:  G Venkataraman; R Raman; V Sasisekharan; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Multivalent conjugates of basic fibroblast growth factor enhance in vitro proliferation and migration of endothelial cells.

Authors:  Aline Zbinden; Shane Browne; Eda I Altiok; Felicia L Svedlund; Wesley M Jackson; Kevin E Healy
Journal:  Biomater Sci       Date:  2018-05-01       Impact factor: 6.843

4.  Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans.

Authors:  G Venkataraman; Z Shriver; J C Davis; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth.

Authors:  L Sherman; D Wainwright; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  1998-04-01       Impact factor: 11.361

6.  Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.

Authors:  M Safran; M Eisenstein; D Aviezer; A Yayon
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

7.  Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.

Authors:  Moreno Zamai; Chithra Hariharan; Dina Pines; Michal Safran; Avner Yayon; Valeria R Caiolfa; Rivka Cohen-Luria; Ehud Pines; Abraham H Parola
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

8.  Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.

Authors:  Michael Fannon; Kimberly Forsten-Williams; Matthew A Nugent; Kalvin J Gregory; Chia Lin Chu; Adrienne L Goerges-Wildt; Dipak Panigrahy; Arja Kaipainen; Carmen Barnes; Cathy Lapp; Yuen Shing
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

9.  Inhibition by acharan sulphate of angiogenesis in experimental inflammation models.

Authors:  Ajoy Kumar Ghosh; Noriyasu Hirasawa; Yeon Sil Lee; Yeong Sik Kim; Kuk Hyun Shin; Nama Ryu; Kazuo Ohuchi
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

10.  Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development.

Authors:  Ann Ng; Michelle Wong; Beth Viviano; Jonathan M Erlich; George Alba; Camila Pflederer; Patrick Y Jay; Scott Saunders
Journal:  Dev Biol       Date:  2009-09-04       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.